Handelsbanken Fonder
HRMY icon

Handelsbanken Fonder’s Harmony Biosciences HRMY Stock Holding History

Handelsbanken Fonder’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$936K Sell
25,700
-11,200
-30% -$353K ﹤0.01% 1172
2026
Q1 		$1.03M Buy
36,900
+13,700
+59% +$449K ﹤0.01% 1021
2025
Q4 		$868K Buy
23,200
+9,700
+72% +$319K ﹤0.01% 1096
2025
Q3 		$372K Hold
13,500
– – ﹤0.01% 1369
2025
Q2 		$427K Hold
13,500
– – ﹤0.01% 1309
2025
Q1 		$448K Hold
13,500
– – ﹤0.01% 1276
2024
Q4 		$465K Buy
13,500
+2,200
+19% +$75.6K ﹤0.01% 1319
2024
Q3 		$452K Buy
11,300
+1,500
+15% +$52.7K ﹤0.01% 1289
2024
Q2 		$296K Buy
9,800
+1,700
+21% +$51.1K ﹤0.01% 1389
2024
Q1 		$272K Hold
8,100
– – ﹤0.01% 1420
2023
Q4 		$262K Hold
8,100
– – ﹤0.01% 1432
2023
Q3 		$265K Hold
8,100
– – ﹤0.01% 1357
2023
Q2 		$285K Hold
8,100
– – ﹤0.01% 1368
2023
Q1 		$264K Sell
8,100
-120,000
-94% -$5.46M ﹤0.01% 1346
2022
Q4 		$7.06M Buy
128,100
+120,000
+1,481% +$6.6M 0.04% 372
2022
Q3 		$359K Hold
8,100
– – ﹤0.01% 1141
2022
Q2 		$395K Hold
8,100
– – ﹤0.01% 1162
2022
Q1 		$394K Hold
8,100
– – ﹤0.01% 1366
2021
Q4 		$345K Buy
+8,100
New +$323K ﹤0.01% 1562

Other funds holding HRMY

CI
CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
SCM
Sidoxia Capital Management Newport Beach, California $136M AUM
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
P
Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Handelsbanken Fonder's HRMY Position: Q2 2026 in Review

Handelsbanken Fonder reduced its Harmony Biosciences (HRMY) stake by 30% in Q2 2026, selling an estimated $353K and leaving 25,700 shares worth $936K. The position accounts for ﹤0.01% of the portfolio, ranked #1172.

Handelsbanken Fonder first reported a position in HRMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $7.06M in Q4 2022. 61 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Handelsbanken Fonder held 25,700 shares of Harmony Biosciences worth $936K as of Q2 2026.
  • Handelsbanken Fonder sold 11,200 Harmony Biosciences shares in Q2 2026, an estimated $353K.
  • Harmony Biosciences made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1172 holding.
  • Handelsbanken Fonder first reported a position in Harmony Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Handelsbanken Fonder's Harmony Biosciences position peaked at $7.06M in Q4 2022.
  • 61 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.